- Market Capitalization, $K 272,720
- Shares Outstanding, K 264,777
- Annual Sales, $ 0 K
- Annual Income, $ -28,620 K
- 60-Month Beta 1.57
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 1.93
|Period||Period Low||Period High||Performance|
| || |
+0.4586 (+80.26%)since 12/22/20
| || |
+0.3564 (+52.91%)since 10/22/20
| || |
-0.2800 (-21.37%)since 01/22/20
GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021
TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering,...
TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced it has entered into a securities purchase agreement with institutional...
, /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...
Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation
Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired the exclusive license to the...
, /PRNewswire/ -- Investments continued flowing into the psychedelic medicine sector this year and will likely continue in 2021 as mental illness cases rise across the globe. The World Health Organization...
|3rd Resistance Point||1.1833|
|2nd Resistance Point||1.1267|
|1st Resistance Point||1.0783|
|1st Support Level||0.9733|
|2nd Support Level||0.9167|
|3rd Support Level||0.8683|